Peptides for Mold Illness: A Map to Better Help you Navigate the Landscape

This is an introduction to a seven part series examining the peptides most discussed in the treatment of CIRS, mold illness and complex chronic illness. We’re going to ignore the influencers, the affiliate links, and the hype, focusing instead on what the science says. I’ll be sure to share my clinical anecdotes along the way. By the end of the series, I hope to provide a balanced perspective on the latest peptides and how/where/if they fit into treating CIRS.

Let’s start this series off with a disclaimer:

This article is for educational purposes only and is not medical advice. The peptides discussed are not approved by Health Canada or the FDA for treating CIRS, and most are not approved for any use. Nothing here is a recommendation to use them. Talk to a qualified healthcare provider before making any treatment decisions.

That’s the unvarnished truth about peptides. They’re all the rage at present. Everyone is using them.

Even though they haven’t been approved for treating anything.

RFK Jr. recently eased US federal restrictions on peptides which means that peptides are no longer banned by the FDA. (source) So, while they’re no longer illegal, the peptide market is still very much akin to the wild west:

There are no standardized manufacturing processes
Companies don’t need an independent evaluation of their products

These are standard regulations that ensure product safety for consumers. Without them, buyer beware has to apply to every internet peptide purchase.

The role of peptides for mold illness and CIRS

Now that I’ve scared you away from ever purchasing an internet peptide, let’s pivot our discussion towards mold, CIRS, and chronic illness. If you’ve spent any time on the CIRS Reddit boards or Facebook groups you’ve probably noticed that peptides are having a moment. They’re in every podcast, every protocol, and every influencer’s affiliate links.

Language like: “three peptides to cure mold illness” “revolutionary,” or, “the future of medicine” are posted across the internet. If you’ve been sick for years and tried everything, claims like this are both off-putting and intoxicating.

Before we go peptide by peptide in the posts that follow, I want to lay out where I’m coming from and how I actually think peptides fit into the treatment of CIRS (if at all). My honest position sits between the hype-based influencers and the hard data-scientists.

Expert Recap: Peptides for Mold Illness

Peptides are a short chain of amino acids, which are the same building blocks proteins are made of. There are unsubstantiated claims that peptides are a cure all for everything from weight loss to tendon injuries. While they are not a cure for CIRS, they can play a small role in treating CIRS. This is especially true for highly sensitive patients, and patients who have completed the Shoemaker Protocol but still haven’t regained their health.

Why I’m writing about peptides

There are two kinds of peptide content online, and neither serves you, dear reader.

Camp One: Team Peptides

The first is the hype crowd. It’s generally written by people selling the peptides, or people who have used the peptide and claim “it changed their life“. This crowd treats every compound as a miracle with no caveats, no missing data, no acknowledgment that “promising in mice” is a very different sentence than “proven in humans.” It uses the word “studies” without telling you what kind, how many, or who ran them.

Camp Two: The Stone Cold Scientists

The second group are the stone cold scientists. They take the position that because these peptides aren’t FDA-approved and lack large human trials, they’re all worthless or dangerous, and anyone using them is a quack. That’s a lazier position to take than it sounds. It’s much easier to completely dismiss an entirely new way of thinking than it is to accept the possibility of some good with the bad.

I want to do something harder than either camp has done thus far. I want to grade the evidence honestly, peptide by peptide, using the actual scientific literature (ie; peer-reviewed journals, not supplement blogs) and tell you how strong the case is for each one. Some of these peptides have human randomized controlled trials behind them. Some have only animal and cell-culture data. One has studies done specifically in CIRS patients, but they’re methodologically weak.

Peptide to peptide, there’s a lot of variance in the data. Treating all peptides the same is how you get misled. The differences are the whole point of this series. With that in mind, let’s jump in!

Where I’m coming from

I treat complex chronic illness for a living, with a particular focus on the patients who don’t get better on standard protocols. I help the hyper-sensitive, the treatment-resistant, the patients who have already cycled through everything offered by established frameworks. For those patients, I’m suspending judgement.

So I’m not writing as an outside skeptic with no skin in the game, and I’m not writing as a vendor either; I don’t have any peptides to sell you.

If you’ve read my work before, you’ll know I tend to be quite centrist in my thinking. I’ve seen peptides help patients when everything else made their symptoms worse. I’ve also watched as influencers claim that using peptides for mold illness is a simple solution (spoiler alert: it’s not).

My commitment in this series is simple: I’ll tell you what the literature actually shows, I’ll cite it, I’ll flag where the evidence is thin or comes from a single research group or exists only in animals, and I won’t pretend plausible is the same as proven. Where I think a peptide is genuinely useful, I’ll say so. Where I think the enthusiasm has outrun the data, I’ll say that too.

Ready to start real recovery?
Book a consult with our team today.

Where peptides actually fit in CIRS treatment

This is why you’re here.

To be clear, peptides are not a cure for mold illness or CIRS. They are not a replacement for the core work of treating CIRS. Treating CIRS is extremely complicated. It’s much more involved than simply taking peptides. The exposure has to be identified and removed. You still have to confirm the environment is safe before you move back in. You still have to address the things that make a building sick and you sicker.

No peptide is a substitute for getting out of a water-damaged building, and anyone that suggests otherwise is wrong. Full stop.

The way I see peptides is as a set of targeted tools for specific problems within a larger treatment plan. I have found them valuable in two situations:

When the patient has done the foundational work and still isn’t well.
When the patient is desperately trying to start treatment but reacts to every binder.

This is where peptides earn their place.

To understand why, it helps to think about what these compounds actually do…

What is a peptide?

A peptide is just a short chain of amino acids. Amino acids are the same building blocks proteins are made of. The body uses peptides as signalling molecules: think of them as instructions that tell your cells how to behave. The therapeutic idea behind peptides is to supply specific signals to your cells that have lost the ability to make or respond to them properly.

Peptides can gently nudge a dysregulated system back toward normal function. That’s an entirely different concept than a drug that blocks a receptor or suppresses a pathway. And this is part of why peptides are interesting for a condition like CIRS, where so much of the problem is dysregulated signalling rather than a single broken part.

The seven peptides in this series

Here are the seven we’ll examine, in order, moving from the strongest human evidence toward the most preliminary and most adjacent. I’ve chosen these seven as they’re the ones I see most frequently in my practice. If you feel I’ve missed an important one, let me know and I’ll be happy to add it to the series.

Thymosin Alpha-1:
- An immune-modulating peptide. The only peptide with human clinical evidence of the group, including large randomized controlled trials.
KPV:
- A small fragment of α-MSH. If you know CIRS, you know MSH. This is the most conceptually CIRS-native peptide here, with solid preclinical anti-inflammatory data.
BPC-157:
- The celebrity peptide. This is the one everyone is currently talking about. From tendon injuries to gut-barrier support and immune system modulation, BPC-157 is said to do it all. But does the evidence support the hype?
VIP:
- Vasoactive intestinal peptide, the only peptide on this list with studies done specifically in CIRS patients, and the one whose CIRS-specific evidence we’ll have to weigh especially carefully.
LL-37:
- Your body’s own antimicrobial peptide, relevant to biofilm and the colonization problems some patients carry, with a genuine dosing paradox worth understanding. Is this the future of MARCoNS treatment?
MOTS-c:
- A mitochondrial-derived peptide aimed at cellular energy and metabolism. This is where the series crosses into mitochondrial biology and the cell danger response (CDR).
Epitalon:
- The pineal/longevity tetrapeptide. Epitalon is the most adjacent and most preliminary of the peptides we’re going to discuss.

A note on each post that follows:

I’ll cover what the peptide is, how it’s thought to work, what the actual published evidence shows, where it might fit in a CIRS treatment plan, and an honest review of the limitations, the safety questions, and the regulatory status.

Remember, these peptides are not approved by Health Canada or the FDA for treating any condition. My goal is that by the end, you’ll be able to tell the difference between a peptide with real evidence behind it and one riding a wave of hype.